Vagus nerve stimulation use and effect in epilepsy: what have we learned? (Q36352575)

13 August 2017

1 reference

title

Vagus nerve stimulation use and effect in epilepsy: what have we learned? (English)

1 reference

13 August 2017

Evelyn S Tecoma

1

1 reference

PubMed ID

16376157

13 August 2017

Vicente J Iragui

series ordinal

2

1 reference

13 August 2017

20 December 2005

1 reference

13 August 2017

1 reference

13 August 2017

8

1 reference

13 August 2017

1

1 reference

13 August 2017

127-136

1 reference

Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus-nerve stimulation for the treatment of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

The evolving place of vagus nerve stimulation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation therapy summary: five years after FDA approval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Therapeutic mechanisms of vagus nerve stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Destruction of peripheral C-fibers does not alter subsequent vagus nerve stimulation-induced seizure suppression in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Effects of vagal stimulation on experimentally induced seizures in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagal stimulation reduces the severity of maximal electroshock seizures in intact rats: use of a cuff electrode for stimulating and recording

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Human vagus nerve electrophysiology: a guide to vagus nerve stimulation parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Acute vagus nerve stimulation using different pulse widths produces varying brain effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagal nerve stimulation: adjustments to reduce painful side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation: analysis of device parameters in 154 patients during the long-term XE5 study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation for epilepsy: randomized comparison of three stimulation paradigms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation for 1 year in 269 patients on unchanged antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Generator replacement in epilepsy patients treated with vagus nerve stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation for pharmacoresistant epilepsy: clinical symptoms with end of service.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Treatment of epilepsy by stimulation of the vagus nerve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Antiepileptic drug use during the first 12 months of vagus nerve stimulation therapy: a registry study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Observations on the use of vagus nerve stimulation earlier in the course of pharmacoresistant epilepsy: patients with seizures for six years or less

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation: predictors of seizure freedom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Efficacy of vagal nerve stimulation in children with medically refractory epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Improvement in alertness and behavior in children treated with combination topiramate and vagus nerve stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation for refractory idiopathic generalised epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Effect of vagus nerve stimulation on adults with pharmacoresistant generalized epilepsy syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation for medication-resistant generalized epilepsy. E04 VNS Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation and Lennox-Gastaut syndrome: a review of the literature and data from the VNS patient registry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation in children with therapy-resistant epilepsy diagnosed as Lennox-Gastaut syndrome: clinical results, neuropsychological effects, and cost-effectiveness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation in pediatric epilepsy: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

VNS therapy in clinical practice in children with refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation in patients with catastrophic childhood epilepsy, a 2-year follow-up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagal nerve stimulation in epileptic encephalopathies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation in 16 children with refractory epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation for drug-resistant epilepsy in children and young adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagal nerve stimulation in the epileptic encephalopathies: 3-year follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Effects of Vagal Nerve Stimulation on Cognition and Quality of Life in Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Video EEG monitoring prior to vagal nerve stimulator implantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation for the treatment of bilateral independent temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Effect of vagal nerve stimulation on patients with bitemporal epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Left vagal nerve stimulation in children with medically refractory epilepsy. The Pediatric VNS Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation therapy in patients younger than 18 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation therapy for epilepsy in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation therapy after failed cranial surgery for intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

VNS in patients with previous unsuccessful resective epilepsy surgery: antiepileptic and psychotropic effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation, side effects, and long-term safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Complications of chronic vagus nerve stimulation for epilepsy in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vocal cord adduction during vagus nerve stimulation for treatment of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Respiratory pattern changes in sleep in children on vagal nerve stimulation for refractory epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Effects of vagus nerve stimulation on respiration during sleep: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagal nerve stimulation induces intermittent hypocapnia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Sleep apnea and excessive daytime somnolence induced by vagal nerve stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation reduces daytime sleepiness in epilepsy patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Heart period variability during vagal nerve stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Neurocardiac responses to vagoafferent electrostimulation in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Effect of vagal nerve electrostimulation on the power spectrum of heart rate variability in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Analysis of RR variability in drug-resistant epilepsy patients chronically treated with vagus nerve stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Ventricular asystole during vagus nerve stimulation for epilepsy in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Bradycardia and asystole with the use of vagus nerve stimulation for the treatment of epilepsy: a rare complication of intraoperative device testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Complete heart block with ventricular asystole during left vagus nerve stimulation for epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation: mood and cognitive effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Influence of Vagus Nerve Stimulation on Vestibulo-Ocular Reflex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Major Psychiatric Disorders Subsequent to Treating Epilepsy by Vagus Nerve Stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation is associated with mood improvements in epilepsy patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation attenuates heat- and formalin-induced pain in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation in awake rats reduces formalin-induced nociceptive behaviour and fos-immunoreactivity in trigeminal nucleus caudalis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

The effect of vagus nerve stimulation on migraines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.006

10.1016/J.YEBEH.2005.09.006

7 January 2021

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16376157